Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to $163392.0.

  • Cumberland Pharmaceuticals' Free Cash Flow fell 6448.96% to $163392.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year increase of 52364.17%. This contributed to the annual value of -$678647.0 for FY2024, which is 11167.55% down from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Free Cash Flow stood at $163392.0 for Q3 2025, which was down 6448.96% from $817315.0 recorded in Q2 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Free Cash Flow peaked at $5.2 million during Q2 2023, and registered a low of -$2.2 million during Q1 2024.
  • Its 5-year average for Free Cash Flow is $1.3 million, with a median of $1.2 million in 2023.
  • As far as peak fluctuations go, Cumberland Pharmaceuticals' Free Cash Flow soared by 167068.18% in 2022, and later tumbled by 75949.66% in 2023.
  • Over the past 5 years, Cumberland Pharmaceuticals' Free Cash Flow (Quarter) stood at $2.0 million in 2021, then surged by 94.38% to $3.8 million in 2022, then tumbled by 73.85% to $991448.0 in 2023, then surged by 91.87% to $1.9 million in 2024, then crashed by 91.41% to $163392.0 in 2025.
  • Its Free Cash Flow stands at $163392.0 for Q3 2025, versus $817315.0 for Q2 2025 and $3.9 million for Q1 2025.